Cancer treatment and survivorship statistics, 2016
暂无分享,去创建一个
A. Jemal | R. Siegel | A. Mariotto | K. Miller | C. Lin | J. Kramer | J. Rowland | K. Stein | Rick Alteri
[1] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[2] A. Cherry,et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. , 2005, Blood.
[3] U. Ekrikpo,et al. Increasing incidence of differentiated thyroid cancer in South East England: 1987–2006 , 2011, European Archives of Oto-Rhino-Laryngology.
[4] L. Schover,et al. Sexual dysfunction and infertility as late effects of cancer treatment , 2014, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].
[5] E. Rivera,et al. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer , 2015, Cancer Chemotherapy and Pharmacology.
[6] Kurt Miller,et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. , 2012, The New England journal of medicine.
[7] E. Gamelin,et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. , 2002, Seminars in oncology.
[8] P. Warde,et al. Impact of androgen deprivation therapy on cardiovascular disease and diabetes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] H. Brenner,et al. Fear of recurrence and disease progression in long‐term (≥5 years) cancer survivors—a systematic review of quantitative studies , 2013, Psycho-oncology.
[10] S. Edge,et al. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[12] Early Breast Cancer Trialists' Collaborative Group. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[13] R. Tuttle,et al. Changing Trends in the Incidence of Thyroid Cancer in the United States. , 2016, JAMA otolaryngology-- head & neck surgery.
[14] D. Kashy,et al. Needs assessment of family caregivers of cancer survivors: three cohorts comparison , 2010, Psycho-oncology.
[15] W. Enker,et al. Long-term Results of Rectal Cancer Surgery with a Systematical Operative Approach , 2013, Annals of Surgical Oncology.
[16] Y. Yamada,et al. Ten‐year outcomes of high‐dose, intensity‐modulated radiotherapy for localized prostate cancer , 2011, Cancer.
[17] Gustavo Werutsky,et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. , 2012, The Lancet. Oncology.
[18] Julia H. Rowland,et al. Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[19] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[20] Kassandra I. Alcaraz,et al. Prevalence and Correlates of Smoking and Cessation-Related Behavior among Survivors of Ten Cancers: Findings from a Nationwide Survey Nine Years after Diagnosis , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[21] A. Goldhirsch,et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] G. Andriole. Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer , 2013 .
[23] K. Dookeran,et al. Racial and Ethnic Differences in Breast Cancer Survival: How Much Is Explained by Screening, Tumor Severity, Biology, Treatment, Comorbidities, and Demographics? , 2008 .
[24] Rebecca Smith-Bindman,et al. Racial and ethnic differences in breast cancer survival , 2008, Cancer.
[25] P. Walsh. 20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, The Journal of urology.
[26] F. Sitas,et al. Smoking cessation after cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] P. Conte,et al. Aromatase Inhibitors in the Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: Putting Safety Issues into Perspective , 2007, The breast journal.
[28] G. Armstrong,et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. , 2013, JAMA.
[29] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[30] H. Kehlet,et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. , 2009, JAMA.
[31] Bob Löwenberg,et al. Review Articles (434 articles) , 2008 .
[32] T. Kipps,et al. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. , 2015, The New England journal of medicine.
[33] L. Strobbe,et al. Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. , 2008, The journal of pain : official journal of the American Pain Society.
[34] P. Warde,et al. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy , 2013, BJU international.
[35] R. Hays,et al. Health‐related quality of life in older adult survivors of selected cancers: Data from the SEER‐MHOS linkage , 2015, Cancer.
[36] A. Bleyer,et al. Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. , 2016, JAMA pediatrics.
[37] C. O’Malley,et al. Diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] B. Lange,et al. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. , 2014, Journal of the National Cancer Institute.
[39] A. Jemal,et al. Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[40] R. Perera,et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. , 2013, JAMA.
[41] M. Santoro,et al. Central role of RET in thyroid cancer. , 2013, Cold Spring Harbor perspectives in biology.
[42] P. Saylor,et al. Metabolic complications of androgen deprivation therapy for prostate cancer. , 2009, The Journal of urology.
[43] A. Niemierko,et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. , 2012, European urology.
[44] J. Moley,et al. Medullary, anaplastic, and metastatic cancers of the thyroid. , 2010, Seminars in oncology.
[45] Prokar Dasgupta,et al. Recent advances in the diagnosis and treatment of bladder cancer , 2013, BMC Medicine.
[46] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[47] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[48] N. Keating,et al. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. , 2012, Journal of the National Cancer Institute.
[49] G. Armstrong,et al. Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study , 2014, Journal of Cancer Survivorship.
[50] N. Parr,et al. Long‐term changes in bone mineral density and predicted fracture risk in patients receiving androgen‐deprivation therapy for prostate cancer, with stratification of treatment based on presenting values , 2009, BJU international.
[51] S. Sindrup,et al. The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer , 2008, British Journal of Cancer.
[52] T. Eberlein,et al. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation , 2012 .
[53] H. Sasaki,et al. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma , 2009, BMC Cancer.
[54] J. Griggs,et al. Use of radioactive iodine for thyroid cancer. , 2011, JAMA.
[55] R. Saskin,et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. , 2014, The Lancet. Oncology.
[56] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .
[57] N. Keating,et al. Receipt of locoregional therapy among young women with breast cancer , 2012, Breast Cancer Research and Treatment.
[58] Xianglin L. Du,et al. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node‐positive, operable breast cancer , 2009, Cancer.
[59] Dirk F Moore,et al. Outcomes of localized prostate cancer following conservative management. , 2009, JAMA.
[60] A. Tsimberidou,et al. Richter's transformation in chronic lymphocytic leukemia. , 2006, Seminars in oncology.
[61] A. Bleyer. Young Adult Oncology: The Patients and Their Survival Challenges , 2007, CA: a cancer journal for clinicians.
[62] I. Tumur,et al. Treatments for chronic myeloid leukemia: a qualitative systematic review , 2012, Journal of blood medicine.
[63] J. Larkin,et al. Pembrolizumab versus Ipilimumab in Advanced Melanoma. , 2015, The New England journal of medicine.
[64] J. Tjandra,et al. Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis , 2007, Diseases of the colon and rectum.
[65] Mel Greaves,et al. Acute lymphoblastic leukaemia , 2013, The Lancet.
[66] I. Ganly,et al. Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy , 2011, Cancer.
[67] G. Armstrong,et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] R. Dellavalle,et al. A Review of Novel Therapies for Melanoma , 2014, American Journal of Clinical Dermatology.
[69] P. Loehrer. Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship , 2008 .
[70] B. Coiffier,et al. State-of-the-art therapeutics: diffuse large B-cell lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] Yu Shyr,et al. Nationwide trends in mastectomy for early-stage breast cancer. , 2015, JAMA surgery.
[72] B. Newman,et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.
[73] F. Saad,et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. , 2013, The New England journal of medicine.
[74] E. Feuer,et al. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020 , 2006, Cancer Causes & Control.
[75] Peter Baade,et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes , 2012, BMC Cancer.
[76] C. Audette,et al. The sexual health of women after gynecologic malignancy. , 2010, Journal of midwifery & women's health.
[77] Eric J Feuer,et al. Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.
[78] N. Boissel,et al. Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase , 2015, Journal of adolescent and young adult oncology.
[79] E. de Azambuja,et al. Improving quality of life after breast cancer: dealing with symptoms. , 2011, Maturitas.
[80] David N Jr Danforth Jr,et al. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors , 2013 .
[81] Michael B Atkins,et al. Which drug, and when, for patients with BRAF-mutant melanoma? , 2013, The Lancet. Oncology.
[82] P. Ganz,et al. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.
[83] E. Kimby,et al. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial , 2015, The Lancet.
[84] L. V. van de Poll-Franse,et al. Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. , 2012, European journal of cancer.
[85] Jim C Hu,et al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. , 2011, JAMA.
[86] James A Hanley,et al. 20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.
[87] P. Mauch,et al. Nodular lymphocyte-predominant hodgkin lymphoma. , 2007, Seminars in radiation oncology.
[88] P. Cinciripini,et al. Tobacco use and cessation for cancer survivors: An overview for clinicians , 2014, CA: a cancer journal for clinicians.
[89] T. Church,et al. Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] M. Hornbrook,et al. Early and Late Complications Among Long-Term Colorectal Cancer Survivors With Ostomy or Anastomosis , 2010, Diseases of the colon and rectum.
[91] S. Laurberg,et al. Impact of bowel dysfunction on quality of life after sphincter‐preserving resection for rectal cancer , 2013, The British journal of surgery.
[92] Daniel J Weisdorf,et al. Acute Myeloid Leukemia. , 2015, The New England journal of medicine.
[93] Andrew Ma,et al. Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries , 2013, Annals of Surgical Oncology.
[94] Ahmedin Jemal,et al. Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[95] R. Fisher,et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.
[96] M. Graefen,et al. Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[97] J. Rasmussen,et al. Recent progress in the treatment and prevention of cancer‐related lymphedema , 2015, CA: a cancer journal for clinicians.
[98] A. Zietman,et al. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. , 2013, The Lancet. Oncology.
[99] C. Orces. Trends in hospitalization for fall-related injury among older adults in the United States, 1988-2005. , 2009 .
[100] Amy Y. Chen,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[101] A. Bleyer,et al. The adolescence of young adult oncology. , 2009, Seminars in oncology.
[102] S. Groshen,et al. Long‐term outcome in patients with a Gleason score ≤6 prostate cancer treated by radical prostatectomy , 2011, BJU international.
[103] D. Rose,et al. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. , 2009, Journal of women's health.
[104] R. Capocaccia,et al. Estimation and projections of cancer prevalence from cancer registry data , 2002, Statistics in medicine.
[105] Stacey A. Kenfield,et al. Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] L. Harlan,et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] L. Robison,et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. , 2013, The Lancet. Oncology.
[108] M. Leitzmann,et al. Adiposity and risk of thyroid cancer: a systematic review and meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[109] Arturo Molina,et al. Abiraterone and increased survival in metastatic prostate cancer. , 2011, The New England journal of medicine.
[110] J. Meyerhardt,et al. Practical clinical interventions for diet, physical activity, and weight control in cancer survivors , 2015, CA: a cancer journal for clinicians.
[111] Richard Lee,et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection and outcomes , 2015 .
[112] D. Brooks,et al. American Cancer Society Colorectal Cancer Survivorship Care Guidelines , 2015, CA: a cancer journal for clinicians.
[113] T. Skolarus,et al. American Cancer Society prostate cancer survivorship care guidelines , 2014, CA: a cancer journal for clinicians.
[114] R. Huddart,et al. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors , 2013 .
[115] R Peto,et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[116] C. Moinpour,et al. Quality of life in long term survivors of colorectal cancer , 2002, American Journal of Gastroenterology.
[117] F. Saad,et al. Enzalutamide in metastatic prostate cancer before chemotherapy. , 2014, The New England journal of medicine.
[118] S. J. LaMonte,et al. American Cancer Society Head and Neck Cancer Survivorship Care Guideline , 2016, CA: a cancer journal for clinicians.
[119] P. Johnstone,et al. Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment , 2009, CA: a cancer journal for clinicians.
[120] Elizabeth B. Habermann,et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients , 2011 .
[121] H. Kantarjian,et al. The biology and therapy of adult acute lymphoblastic leukemia , 2003, Cancer.
[122] Suzanne G. Leveille,et al. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review. , 2013, Lung cancer.
[123] S. L. Stewart,et al. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. , 2011, Journal of the American Academy of Dermatology.
[124] J. Lortet-Tieulent,et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening , 2016, CA: a cancer journal for clinicians.
[125] Gary H Lyman,et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[126] W Lutzeyer,et al. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.
[127] S. Loening,et al. Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.
[128] Michael Hallek,et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. , 2014, The New England journal of medicine.
[129] Dirk Schadendorf,et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.
[130] A. D'Amico,et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. , 2010, Circulation.
[131] N. Keating,et al. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. , 2016, Clinical breast cancer.
[132] B. Hancock,et al. Non-Hodgkin lymphoma , 2003, The Lancet.
[133] A. Jemal,et al. Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[134] M. Proschan,et al. Randomized Trials of Breast-Conserving Therapy Versus Mastectomy for Primary Breast Cancer: A Pooled Analysis of Updated Results , 2005, American journal of clinical oncology.